Pregabaline CNX 165 mg tabletten met verlengde afgifte

{
  "form": "Tablet met verlengde afgifte",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h130391_smpc.pdf",
  "strength": null,
  "atc_label": "Pregabalin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg130391",
  "excipients": [
    "AMMONIA (E 527)",
    "BASISCH GEBUTYLEERD METHACRYLAAT COPOLYMEER (E 1205)",
    "CROSPOVIDON (E 1202)",
    "HYPROLOSE (E 463)",
    "HYPROMELLOSE 2208 (Release controlling polymer), K15M (E 464)",
    "HYPROMELLOSE 2208, K100 (E 464)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ROOD  (E 172)",
    "IJZEROXIDE ZWART (E 172)",
    "MACROGOL 3350",
    "MAGNESIUMSTEARAAT (E 470b)",
    "POLYVINYLALCOHOL (E 1203)",
    "PROPYLEENGLYCOL (E 1520)",
    "SCHELLAK GLAZE, GEDEELTELIJK VERESTERD",
    "SILICIUMDIOXIDE (E 551)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)",
    "ZWARTE INKT"
  ],
  "substances": [
    "PREGABALINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h130391.pdf",
  "authorised_at": "2024/04/08",
  "procedure_number": "NL/H/5677/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "130391",
  "additional_monitoring": "N"
}